Report Categories

Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.

USD3480.00

Add To Cart

Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.

USD4480.00

Add To Cart

Microphysiological systems (MPS), also known as organ-on-a-chip systems, and organoids are innovative technologies used in biomedical research to model human physiology and diseases in vitro. MPS are microscale platforms that mimic the structure and function of human organs or tissues, typically incorporating cells, scaffolds, and microfluidic channels to create microenvironments that replicate physiological conditions. Organoids, on the other hand, are three-dimensional clusters of cells grown from stem cells or tissue samples that self-organize and differentiate into structures resembling specific organs. These systems offer unique advantages for studying human biology and disease mechanisms, enabling researchers to recapitulate complex tissue architecture and cellular interactions in a controlled laboratory setting. MPS and organoids hold great promise for drug discovery, toxicity testing, disease modeling, and personalized medicine applications, facilitating the development of more effective therapies and treatments.

USD4480.00

Add To Cart

Microphysiological systems (MPS), also known as organ-on-a-chip systems, and organoids are innovative technologies used in biomedical research to model human physiology and diseases in vitro. MPS are microscale platforms that mimic the structure and function of human organs or tissues, typically incorporating cells, scaffolds, and microfluidic channels to create microenvironments that replicate physiological conditions. Organoids, on the other hand, are three-dimensional clusters of cells grown from stem cells or tissue samples that self-organize and differentiate into structures resembling specific organs. These systems offer unique advantages for studying human biology and disease mechanisms, enabling researchers to recapitulate complex tissue architecture and cellular interactions in a controlled laboratory setting. MPS and organoids hold great promise for drug discovery, toxicity testing, disease modeling, and personalized medicine applications, facilitating the development of more effective therapies and treatments.

USD3480.00

Add To Cart

The global Microphysiological System market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

According to our (Global Info Research) latest study, the global Microphysiological System market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

USD3480.00

Add To Cart